Ikesia Biologics Private Limited, a active private limited company, was established on 10 June 2022 in Bangalore, Karnataka, India. Engaging in science research within the research & development sector, it holds CIN: U73100KA2022PTC162282. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sawraj Singh (Director), Rekha Nagpal (Director). It holds ₹5.00 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Lab Unit No. Mepl03, Bangalore Helix Biotech Park, Electronic City Phase - 1,, Bangalore, Karnataka, 560100.
U73100KA2022PTC162282
162282
10 June 2022
₹1.50 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Ikesia Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sawraj Singh | Director | 10 Jun 2022 | Current |
| Rekha Nagpal | Director | 19 Oct 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ikesia Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ikesia Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2023 | Others | ₹0.60 M | Satisfied |
| 22 Dec 2023 | Others | ₹4.40 M | Satisfied |
Explore comprehensive loan charge details -
Ikesia Biologics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ikesia Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikesia Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 22 Dec 2023 via Charge ID 100853353 with Others was fully satisfied on 18 Jul 2025. was documented.
A charge registered on 22 Dec 2023 via Charge ID 100853351 with Others was fully satisfied on 03 Jul 2025. was recorded as a recent event.
Progress on Ikesia Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Ikesia Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
A charge with Others amounted to Rs. 4.40 M with Charge ID 100853351 was registered on 22 Dec 2023. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.60 M with Charge ID 100853353 was registered on 22 Dec 2023. was completed.
The CIN of Ikesia Biologics Private Limited is U73100KA2022PTC162282.
Ikesia Biologics Private Limited is headquartered at Lab Unit No. Mepl03, Bangalore Helix Biotech Park, Electronic City Phase - 1,, Bangalore, Karnataka, 560100.
Ikesia Biologics Private Limited was incorporated on 10 June 2022.
The current directors of Ikesia Biologics Private Limited are
The primary industry of Ikesia Biologics Private Limited is Research & Development.
Ikesia Biologics Private Limited is unlisted.
The authorized capital of Ikesia Biologics Private Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Ikesia Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX